The Video Journal of Hematology & Hematological Oncology (VJHemOnc) is a global, open-access video journal, dedicated to providing trusted and up-to-date medical information in order to improve the awareness and understanding of hematological cancers. Our goal is to expedite learning through the sharing of new data and expert opinion, and to rapidly disseminate the latest news and information to healthcare professionals, worldwide, on a range of innovative digital media - including video and blog formats. VJHemOnc content is led by an editorial board of highly respected thought leaders with a combined expertise that spans the spectrum of hematological cancers. All content is created and published under the guidance of this board of world-leading experts.
I'm going to enter a clinical trial with vibecotamab in about 3-4 days. After four remissions and two stem cell transplants, I would really like to find something that gets me out of the 'medical merry-go-round. . I'm 77.
Check out the latest in rare diseases, including smoldering myeloma, rare lymphomas, rare MPNs, and more, on our site: 👉www.vjhemonc.com/subject/rare-diseases/
Visit our site and explore the latest updates in AML with our expert interviews, roundtable discussions, features, and more: www.vjhemonc.com/subject/acute-myeloid-leukemia/